Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa

ClinicalTrials.gov ID: NCT02216071

Public ClinicalTrials.gov record NCT02216071. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study of the Comparative Efficacy and Safety of EXL CDOS in Subjects With Acute Otitis Externa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to demonstrate the clinical therapeutic non-inferiority of EXL CDOS to commercially available Ciprofloxacin 0.3% and Dexamethasone 0.1% Sterile Otic Suspension (Ciprodex®, Alcon) in the treatment of acute otitis externa (AOE) when administered twice daily for 7 days.

Study identification

NCT ID
NCT02216071
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Exela Pharma Sciences, LLC.
Industry
Enrollment
499 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Months and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 20, 2014 (Actual)
Primary completion
Aug 11, 2015 (Actual)
Completion
Aug 11, 2015 (Actual)
Last update posted
May 28, 2021

2014 – 2015

United States locations

U.S. sites
46
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Birmingham Pediatric Associates Birmingham Alabama 35205 —
Desert Clinical Research/Clinical Research Advantage, Inc. Mesa Arizona 85213 —
Children's Clinic of Jonesboro, PA Jonesboro Arkansas 72401 —
NEA Baptist Clinic Jonesboro Arkansas 72401 —
Southland Clinical Research Center Anaheim California 92804 —
Southland Clinical Reseach Center Bellflower California 90706 —
Alessi Institute Beverly Hills California 90212 —
American Clinical Trials Buena Park California 90620 —
MCS Clinical Trials Los Angeles California 90017 —
Sacramento Ear, Nose and Throat Surgical and Medical Group, Inc Sacramento California 95815 —
Benchmark Research Sacramento California 95822 —
Clinix Health Services of Colorado/Clinical Research Advantage, Inc. Centennial Colorado 80112 —
Colorado ENT & Allergy Colorado Springs Colorado 80909 —
Colorado Springs Health Partners/Clinical Research Advantage, Inc. Colorado Springs Colorado 80920 —
Direct Helpers Medical Center Hialeah Florida 33012 —
Palm Springs Research Institute Hialeah Florida 33012 —
Abel & Buchheim PR, Inc. Miami Florida 33165 —
Integrity Clinical Trials, LLC Miami Florida 33165 —
Pediatrics & Adolescent Medicine, PA Marietta Georgia 30062 —
Urban Family Practice/Clinical Research Advantage Marietta Georgia 30067 —
Professional Research Network of Kansas, LLC Wichita Kansas 67203 —
Horizon Research Group, LLC Eunice Louisiana 70535 —
Woburn Pediatric Associates Woburn Massachusetts 01801 —
Pioneer Clinical Research Bellevue Nebraska 68005 —
Clinical Research Center for Nevada, LLC Las Vegas Nevada 89104 —
ProMetrix Clinical Studies Morganville New Jersey 07751 —
Whitehouse Station Family Medicine Whitehouse Station New Jersey 08889 —
Asheboro Research Associates Asheboro North Carolina 27203 —
Piedmont Ear, Nose, and Throat Associates Winston-Salem North Carolina 27103 —
Sterling Research Group, Ltd Cincinnati Ohio 45246 —
Hometown Urgent Care and Research Dayton Ohio 45424 —
Cyn3rgy Research Gresham Oregon 97030 —
Research Across America Dallas Texas 75234 —
Gulf Coast Medical Research Houston Texas 77025 —
Gulf Coast Medical Research Missouri City Texas 77459 —
Benchmark Research San Angelo Texas 76904 —
Mercury Clinical Research, Inc Splendora Texas 77372 —
Gulf Coast Medical Research Sugar Land Texas 77478 —
Ericksen Research & Development Clinton Utah 84015 —
J. Lewis Research/First Med East Salt Lake City Utah 84121 —
J. Lewis Research/Foothill Family Clinic South Salt Lake City Utah 84121 —
Chyrsalis Clinical Research St. George Utah 84790 —
Pi-Coor Clinical Research, LLC Burke Virginia 22015 —
Pediatric Research of Charlottesville, LLC Charlottesville Virginia 22902 —
Heugenot Pediatrics, PC Midlothian Virginia 23113 —
Zain Research, LLC Richland Washington 97030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02216071, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02216071 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →